Clinical trial

Levodopa Concentration Profile With Stalevo 75/125 mg

NCT01070628

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-12-01

PhasePHASE1

Study timeline

Study start (unknown)2009-12-01Date precision: month

Registry last updated2010-08-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Interventions

Stalevo (levodopa/ carbidopa/ entacapone)DRUG

Sinemet (levodopa/carbidopa)DRUG

Sponsors & collaborators

Orion Corporation, Orion Pharmalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01070628 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.